Healthcare actual property entered 2026 with robust fundamentals intact, together with excessive occupancy, predictable revenue streams and mission-critical tenancy, Companion Valuation Advisors stated in its newly issued Q1 2026 Healthcare & Life Sciences Market Report. These traits have continued to draw investor consideration, notably as broader market uncertainty persists.
Transaction exercise, whereas measured, has gained momentum because the second half of 2025 and continues into early 2026. Traders are re-engaging with a disciplined strategy, prioritizing high-quality belongings with secure money move and long-term demand drivers. Portfolio-level transactions have additionally re-emerged this yr.
“As pricing has change into clearer, we’re seeing capital re-engage with extra self-discipline,” stated Erik Hill, managing director and Nationwide Follow Lead for Healthcare & Life Sciences at Companion Valuation Advisors. “Traders are centered on high quality, sturdy money move and long-term demand, which is driving a extra secure and intentional transaction setting in healthcare actual property.”
